» Articles » PMID: 37073428

Evaluating Motion of Pancreatic Tumors and Anatomical Surrogates Using Cine MRI in 0.35T MRgRT Under Free Breathing Conditions

Overview
Date 2023 Apr 19
PMID 37073428
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment tolerability is a significant limitation to pancreatic cancer treatment with radiotherapy due to proximity to highly radiosensitive organs and respiratory motion necessitating expanded target margins. Further, pancreatic tumors are difficult to visualize on conventional radiotherapy systems. Surrogates are often used to locate the tumor but are often inconsistent and do not provide strong positional relations throughout the respiratory cycle. This work utilizes a retrospective dataset of 45 pancreatic cancer patients treated on an MR-Linac system with cine MRI acquired for real-time target tracking. We investigated intra-fraction motion of tumors and two abdominal surrogates, leading to prediction models between the tumor and surrogate. Patient specific motion evaluation and prediction models were generated from 225 cine MRI series acquired during treatment. Tumor contours were used to evaluate the pancreatic tumor motion. Linear regression and principal component analysis (PCA) based models were used to predict tumor position from the anterior-posterior (AP) motion of the abdominal surface, the superior-inferior (SI) motion of the diaphragm, or a combination. Models were evaluated using mean squared error (MSE) and mean absolute error (MAE). Contour analysis showed the average pancreatic tumor motion range was 7.4 ± 2.7 mm and 14.9 ± 5.8 mm in the AP and SI directions, respectively. The PCA model had MSE of 1.4 mm and 0.6 mm , for the SI and AP directions, respectively, with both surrogates as inputs for the models. When only the abdomen surrogate was used, MSE was 1.3 mm and 0.4 mm in the SI and AP directions, while it was 0.4 mm and 1.3 mm when only the diaphragm surrogate was used. We evaluated intra-fraction pancreatic tumor motion and demonstrated prediction models between the tumor and surrogate. The models calculated the pancreatic tumor position from diaphragm, abdominal, or both contours within standard pancreatic cancer target margin, and the process could be applied to other disease sites in the abdominothoracic cavity.

Citing Articles

Surrogate gating strategies for the Elekta Unity MR-Linac gating system.

Rusu S, Smith B, St-Aubin J, Shaffer N, Hyer D J Appl Clin Med Phys. 2024; 26(2):e14566.

PMID: 39540669 PMC: 11799906. DOI: 10.1002/acm2.14566.


Analysis of sagittal plane cine magnetic resonance imaging for measurement of pancreatic tumor residual motion during breath hold and evaluation of gating margins used in radiotherapy treatment.

Phipps A, Robinson M, George B, Whyntie T J Appl Clin Med Phys. 2024; 26(1):e14557.

PMID: 39496068 PMC: 11712868. DOI: 10.1002/acm2.14557.


MR signature matching (MRSIGMA) implementation for true real-time free-breathing volumetric imaging with sub-200 ms latency on an MR-Linac.

Siddiq S, Murray V, Tyagi N, Borman P, Gui C, Crane C Magn Reson Med. 2024; 92(3):1162-1176.

PMID: 38576131 PMC: 11209806. DOI: 10.1002/mrm.30097.


Evaluation of clinical parallel workflow in online adaptive MR-guided Radiotherapy: A detailed assessment of treatment session times.

Votta C, Iacovone S, Turco G, Carrozzo V, Vagni M, Scalia A Tech Innov Patient Support Radiat Oncol. 2024; 29:100239.

PMID: 38405058 PMC: 10883837. DOI: 10.1016/j.tipsro.2024.100239.


Ultrasound Imaging with Flexible Array Transducer for Pancreatic Cancer Radiation Therapy.

Huang X, Hooshangnejad H, China D, Feng Z, Lee J, Bell M Cancers (Basel). 2023; 15(13).

PMID: 37444403 PMC: 10340354. DOI: 10.3390/cancers15133294.


References
1.
Rudra S, Jiang N, Rosenberg S, Olsen J, Roach M, Wan L . Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Med. 2019; 8(5):2123-2132. PMC: 6536981. DOI: 10.1002/cam4.2100. View

2.
Dolde K, Zhang Y, Chaudhri N, David C, Kachelriess M, Lomax A . 4DMRI-based investigation on the interplay effect for pencil beam scanning proton therapy of pancreatic cancer patients. Radiat Oncol. 2019; 14(1):30. PMC: 6367829. DOI: 10.1186/s13014-019-1231-2. View

3.
Feng M, Balter J, Normolle D, Adusumilli S, Cao Y, Chenevert T . Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution. Int J Radiat Oncol Biol Phys. 2009; 74(3):884-91. PMC: 2691867. DOI: 10.1016/j.ijrobp.2009.02.003. View

4.
Kluter S . Technical design and concept of a 0.35 T MR-Linac. Clin Transl Radiat Oncol. 2019; 18:98-101. PMC: 6630153. DOI: 10.1016/j.ctro.2019.04.007. View

5.
Dawson L, Menard C . Imaging in radiation oncology: a perspective. Oncologist. 2010; 15(4):338-49. PMC: 3227970. DOI: 10.1634/theoncologist.2009-S106. View